TOMI Service Network Members Experience a Surge in SteraMist Business
FREDERICK, Md., Dec. 22, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection...
Staff
Acer Therapeutics Announces Full Enrollment of Pivotal Bioequivalence Trial of ACER-001 for Urea Cycle Disorders
Topline trial results expected in Q1 2021; targeting a pre-NDA meeting with FDA in Q2 2021NEWTON, Mass., Dec. 22, 2020...
Resonant Appoints Industry Thought Leader Dr. Peter Gammel to Advisory Board
Semiconductor Industry Veteran to Join Advisory LeadershipAUSTIN, Texas, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader...
Grey Cloak Tech Completes Successful Pilot Study on its Fuel4Thought™ Migraine Formula with Positive Results
Fuel4Thought™ proprietary Migraine formulation is similar to their recently released Brain Booster, but scientifically designed to try and provide millions...
Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses
CDI-45205 holds potential as a therapeutic and as a prophylactic to protect against coronavirus transmission, including SARS-CoV-2 BOTHELL, Wash., Dec....
Monopar Announces Issuance of U.S. Patent Covering Compositions of Matter for a Novel Family of Camsirubicin Analogs
-Issued patent expands and strengthens Monopar’s existing camsirubicin IP portfolio-Phase 2 initiation for camsirubicin in advanced soft tissue sarcoma remains...
Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection
BioIntelliSense_Sticker Clinicians_view_patient_data_on_tablet-ALI-global December 22, 2020 In 2,500-person trial, partners to validate FDA-cleared BioSticker for clinical confidence in detecting infection Cambridge,...
TRACON Pharmaceuticals Announces $8.8 Million Registered Direct Offering
SAN DIEGO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
Eyesight Max Reviews – Best Vision Loss Supplement? – Product Review by Mike Vaughn
Eyesight Max is a supplement that supports your vision, no matter what age you are and no matter how bad...
Option Care Health to Participate in Upcoming Virtual Investor Conference
BANNOCKBURN, Ill., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest...
Inspire Medical Systems, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
FOSTER CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking...
Kiniksa Announces Data from U.S. Investigator-Initiated Study of Mavrilimumab in Severe COVID-19 Pneumonia and Hyperinflammation
- Early signal of efficacy with trends toward lower mortality and shorter duration of mechanical ventilation in patients treated with...
SCYNEXIS Announces Closing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
JERSEY CITY, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously...
Novus Therapeutics Announces Results of Special Meeting of Stockholders
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused...
Carrot Enters Global Market for Tobacco Cessation with CE Mark Certification for its Breath Sensor
Clinically Proven to Increase the Motivation to Quit, the Company’s Device is the First Ever FDA-Cleared Breath Sensor for Consumer...
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
RenovaCare 2021 Outlook RenovaCare Discusses 2020 Highlights and Provides 2021 Outlook RenovaCare Chairman & CEO, Alan L. Rubino Alan L....
Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures
- Strategic investment from single biotech-focused institutional investor - - Enables clinical development of both fadraciclib and CYC140 in hematological...
Salarius Pharmaceuticals to Participate in Biotech Showcase Digital and BIO @ JPM During “J.P. Morgan Week 2021”
HOUSTON, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company developing potential new medicines for patients...
Vaxil Retains Investor Engagement and Marketing Firm
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 22, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO...